Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P70
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vandeveer, Amanda
Fallon, Jonathan
Tighe, Robert
Sabzevari, Helen
Schlom, Jeffrey
Greiner, John
Article History
First Online: 4 November 2015